XENE logo

Xenon Pharmaceuticals Inc. (XENE) Retained Earnings

Annual Retained Earnings:

-$899.47M-$234.33M(-35.23%)
December 31, 2024

Summary

  • As of today, XENE annual retained earnings is -$899.47 million, with the most recent change of -$234.33 million (-35.23%) on December 31, 2024.
  • During the last 3 years, XENE annual retained earnings has fallen by -$542.10 million (-151.69%).
  • XENE annual retained earnings is now -767.09% below its all-time high of -$103.73 million, reached on December 31, 2014.

Performance

XENE Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXENEbalance sheet metrics

Quarterly Retained Earnings:

-$1.05B-$84.71M(-8.78%)
June 1, 2025

Summary

  • As of today, XENE quarterly retained earnings is -$1.05 billion, with the most recent change of -$84.71 million (-8.78%) on June 1, 2025.
  • Over the past year, XENE quarterly retained earnings has dropped by -$278.23 million (-36.09%).
  • XENE quarterly retained earnings is now -911.46% below its all-time high of -$103.73 million, reached on December 31, 2014.

Performance

XENE Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXENEbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

XENE Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-35.2%-36.1%
3Y3 Years-151.7%-157.0%
5Y5 Years-260.3%-307.8%

XENE Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-151.7%at low-135.6%at low
5Y5-Year-260.3%at low-294.2%at low
All-TimeAll-Time-767.1%at low-911.5%at low

XENE Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$1.05B(-8.8%)
Mar 2025
-
-$964.52M(-7.2%)
Dec 2024
-$899.47M(-35.2%)
-$899.47M(-7.9%)
Sep 2024
-
-$833.78M(-8.1%)
Jun 2024
-
-$771.00M(-8.1%)
Mar 2024
-
-$713.07M(-7.2%)
Dec 2023
-$665.14M(-37.8%)
-$665.14M(-7.2%)
Sep 2023
-
-$620.40M(-8.5%)
Jun 2023
-
-$571.93M(-9.0%)
Mar 2023
-
-$524.47M(-8.6%)
Dec 2022
-$482.75M(-35.1%)
-$482.75M(-8.4%)
Sep 2022
-
-$445.35M(-9.1%)
Jun 2022
-
-$408.20M(-8.3%)
Mar 2022
-
-$377.04M(-5.5%)
Dec 2021
-$357.37M(-28.3%)
-$357.37M(-7.7%)
Sep 2021
-
-$331.81M(-4.9%)
Jun 2021
-
-$316.37M(-7.5%)
Mar 2021
-
-$294.26M(-5.7%)
Dec 2020
-$278.49M(-11.6%)
-$278.49M(-4.6%)
Sep 2020
-
-$266.17M(-3.4%)
Jun 2020
-
-$257.31M(-0.1%)
Mar 2020
-
-$257.14M(-3.0%)
Dec 2019
-$249.66M
-$249.66M(-4.8%)
DateAnnualQuarterly
Sep 2019
-
-$238.28M(-3.9%)
Jun 2019
-
-$229.41M(-4.6%)
Mar 2019
-
-$219.40M(-5.5%)
Dec 2018
-$207.88M(-19.9%)
-$207.88M(-4.3%)
Sep 2018
-
-$199.33M(-7.8%)
Jun 2018
-
-$184.94M(-4.4%)
Mar 2018
-
-$177.14M(-2.2%)
Dec 2017
-$173.39M(-21.5%)
-$173.39M(-4.9%)
Sep 2017
-
-$165.32M(-4.9%)
Jun 2017
-
-$157.58M(-4.9%)
Mar 2017
-
-$150.20M(-5.3%)
Dec 2016
-$142.68M(-19.2%)
-$142.68M(-4.4%)
Sep 2016
-
-$136.70M(-6.0%)
Jun 2016
-
-$128.97M(-4.9%)
Mar 2016
-
-$122.96M(-2.7%)
Dec 2015
-$119.69M(-15.4%)
-$119.69M(-3.4%)
Sep 2015
-
-$115.75M(-3.5%)
Jun 2015
-
-$111.80M(-3.5%)
Mar 2015
-
-$108.00M(-4.1%)
Dec 2014
-$103.73M(+11.2%)
-$103.73M(+1.2%)
Sep 2014
-
-$104.96M(+8.1%)
Jun 2014
-
-$114.15M(+2.2%)
Dec 2013
-$116.75M(+9.3%)
-$116.75M
Dec 2012
-$128.78M
-

FAQ

  • What is Xenon Pharmaceuticals Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Xenon Pharmaceuticals Inc.?
  • What is Xenon Pharmaceuticals Inc. annual retained earnings year-on-year change?
  • What is Xenon Pharmaceuticals Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Xenon Pharmaceuticals Inc.?
  • What is Xenon Pharmaceuticals Inc. quarterly retained earnings year-on-year change?

What is Xenon Pharmaceuticals Inc. annual retained earnings?

The current annual retained earnings of XENE is -$899.47M

What is the all-time high annual retained earnings for Xenon Pharmaceuticals Inc.?

Xenon Pharmaceuticals Inc. all-time high annual retained earnings is -$103.73M

What is Xenon Pharmaceuticals Inc. annual retained earnings year-on-year change?

Over the past year, XENE annual retained earnings has changed by -$234.33M (-35.23%)

What is Xenon Pharmaceuticals Inc. quarterly retained earnings?

The current quarterly retained earnings of XENE is -$1.05B

What is the all-time high quarterly retained earnings for Xenon Pharmaceuticals Inc.?

Xenon Pharmaceuticals Inc. all-time high quarterly retained earnings is -$103.73M

What is Xenon Pharmaceuticals Inc. quarterly retained earnings year-on-year change?

Over the past year, XENE quarterly retained earnings has changed by -$278.23M (-36.09%)
On this page